Comunicación

Publicaciones

  • Recent changes in Europe’s cocaine market: results from an EMCDDA trendspotter study

    Recent changes in Europe’s cocaine market: results from an EMCDDA trendspotter study

    EMCDDA. European Monitoring Centre for Drugs and Drug Addiction

    Using trendspotter methodology, this report explores signs of increasing availability and consumption of cocaine in Europe, in an effort to increase our understanding of recent changes in the cocaine market. The study investigates the consequences of these developments on acute health harms linked to cocaine and crack use and reviews the current public health responses to problems related to these drugs.

    Acceder en inglés
  • Entre la igualdad legal y la discriminación de hecho. Recomendaciones del Comité para la Eliminación de la Discriminación contra la Mujer (CEDAW) a los Estados de América Latina y el Caribe

    Entre la igualdad legal y la discriminación de hecho. Recomendaciones del Comité para la Eliminación de la Discriminación contra la Mujer (CEDAW) a los Estados de América Latina y el Caribe

    Los Estados de América Latina y el Caribe han ratificado la Convención para la Eliminación de todas las formas de Discriminación contra la Mujer (CEDAW por sus siglas en inglés), no obstante la igualdad sustantiva entre hombres y mujeres en América Latina y el Caribe sigue siendo un gran desafío. En este trabajo se examinan las Observaciones Finales y Recomendaciones del Comité CEDAW a los países de la región. En la primera sección de este trabajo se presenta una introducción metodológica y conceptual sobre la autonomía, el empoderamiento y los derechos de las mujeres contemplados en la CEDAW. En el segundo capítulo se examinan los avances y desafíos en la garantía de los derechos de las mujeres a través del análisis de las Observaciones y Recomendaciones generales del Comité CEDAW a los países de América Latina y el Caribe. Finalmente, se presentan algunas conclusiones basadas en la reflexión de los capítulos anteriores.

    Acceder
  • Medical use of cannabis and cannabinoids: questions and answers for policymaking

    Medical use of cannabis and cannabinoids: questions and answers for policymaking

    EMCDDA. European Monitoring Centre for Drugs and Drug Addiction

    What is the evidence base for the medical use of cannabis and cannabinoids? What is the difference between cannabis preparations and medicinal products and why is this important? How is this issue regulated in the EU? These and other questions are explored in this report which responds to growing interest in this topic as more European countries develop policies and practice in this area.  

    Acceder en inglés
  • Institutional and Coordination Mechanisms guidance: Guidance Note on Facilitating Integration and Coherence for SDG Implementation

    Institutional and Coordination Mechanisms guidance: Guidance Note on Facilitating Integration and Coherence for SDG Implementation

    UNDP

    The UNDP Institutional and Coordination Mechanisms guidance note aims to provide information on how countries have adapted their existing institutional and coordination frameworks or established new ones in order to implement the SDGs. It highlights efforts to mobilize institutions around the SDGs, improve their functioning and promote horizontal and vertical coherence. The guidance note includes information on how responsibility is allocated amongst various levels of government (national, subnational and local) for coherent implementation and review of the 2030 Agenda. It provides an overview of key factors a country should take into account when establishing a new institutional framework or adapting an existing one.

    Acceder en inglés
  • The War on Drugs: Harming, not protecting, young people

    The War on Drugs: Harming, not protecting, young people

    Count the costs

    The global war on drugs has been fought for 50 years, without preventing the long-term trend of increasing drug production, supply and use. But beyond this failure to achieve its own stated aims, the drug war has also produced a range of serious, negative costs. Many of these costs have been identified by the United Nations Office on Drugs and Crime (UNODC) – the very UN agency that oversees the system responsible for them – and are described as the ‘unintended consequences’ of the war on drugs. They may have been unintended, but after more than 50 years, they can no longer be seen as unanticipated. These costs are distinct from those relating to drug use, stemming as they do from the choice of a punitive, enforcement-led approach, the burden of which – as with all wars – tends to fall most heavily on the most vulnerable in society, including children and young people. This briefing summarises these costs. 

    Acceder en inglés

Próximas actividades

  • 2ª Reunión del Grupo de Trabajo 2 COPOLAD II en el ámbito de precursores

    Reducción de la Oferta de Drogas

    26/02/19 - 27/02/19

    Bruselas, Bélgica

  • 2ª Reunión del Grupo de Trabajo 1 COPOLAD II en el ámbito de precursores

    Reducción de la Oferta de Drogas

    28/02/19 - 01/03/19

    Bruselas, Bélgica

  • 3ª Reunión Anual de Observatorios Nacionales de Drogas COPOLAD II

    Observatorios Nacionales de Drogas

    25/03/19 - 29/03/19

    Praga, República Checa

Ver todas las actividades